-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EQKJtYTd7IKGZ6ZAH1S9O+11N2YaJUDKAYIR7nsQLIqV5XgjZS4LI5kH0nCi9dde IM7oeSe+X+44bvAQfB5fdw== 0000069499-07-000032.txt : 20070731 0000069499-07-000032.hdr.sgml : 20070731 20070731172348 ACCESSION NUMBER: 0000069499-07-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070727 FILED AS OF DATE: 20070731 DATE AS OF CHANGE: 20070731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN LABORATORIES INC CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRESCH HEATHER M CENTRAL INDEX KEY: 0001280753 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 071013596 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-07-27 0 0000069499 MYLAN LABORATORIES INC MYL 0001280753 BRESCH HEATHER M 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 0 1 0 0 Head of North American Ops. Emp. Stock Option - Right to Buy 15.8 2007-07-27 4 A 0 160000 0 A 2008-07-27 2017-07-27 Common Stock 160000 160000 D Restricted Stock Units 0 2007-07-27 4 A 0 32964 0 A Common Stock 32964 32964 D These options vest in four equal annual installments beginning on 07/27/2008. Each restricted stock unit (RSU) represents the right to receive one share of Mylan Laboratories Inc. common stock. The RSUs vest in three annual installments as follows: 20% on 7/27/08, 30% on 7/27/09 and the remaining 50% on 7/27/10. /s/Heather M. Bresch 2007-07-31 -----END PRIVACY-ENHANCED MESSAGE-----